. Author manuscript; available in PMC: 2024 Oct 1.

Published in final edited form as: Am J Prev Med. 2023 Apr 25;65(4):640–648. doi: 10.1016/j.amepre.2023.04.011

Table 2.

Mean systolic blood pressure change from the baseline pre-guideline (2016–2017) to the post-guideline (2018–2019) visit

Group	Not reclassified (SBP 120–129)			Reclassified to stage 1 hypertension (SBP 130–139)			Reclassified to stage 2 hypertension (SBP 140–159)
Group	Pre-Guideline	Post-Guideline	Difference (95% CI)	Pre-Guideline	Post-Guideline	Difference (9 5% CI)	Pre-Guideline	Post-Guideline	Difference (95% CI)
Overall	124.7	128.9	4.1 (3.0, 5.3)	134.7	133.6	−1.1 (−2.3, 0.1)	148.4	142.6	−5.7 (−6.8, −4.7)
No antihypertensive	124.7	126.4	1.7 (−0.2, 3.6)	134.7	133.4	−1.2 (−3.4, 0.9)	147.5	143.7	−3.8 (−6.0, −1.6)
Antihypertensive	124.7	129.7	5.0 (3.6, 6.3)	134.7	133.7	−1.0 (−2.4, 0.3)	148.6	142.3	−6.3 (−7.6, −5.0)

Data presented are in units of mmHg. SBP: systolic blood pressure